Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin sodium–clavulanate potassium vs amoxicillin sodium–sulbactam for acute moderate to severe bacterial infections
CTR20150311Phase 2Active
- Sponsor
- Shandong Truilin Pharmaceutical Technology Development
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amoxicillin + clavulanate in Airways Infection, chronic bronchitis (CB), acute bronchitis, pneumonia, purulent tonsillitis, sponsored by Shandong Truilin Pharmaceutical Technology Development. Started May 2015; status: active.
02
Drugs
amoxicillin + clavulanate
03
Conditions
Airways Infectionchronic bronchitis (CB)acute bronchitispneumoniapurulent tonsillitis
Beyond the preview
Go deeper on CTR20150311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150311.